{
  "content": [
    {
      "type": "text",
      "text": "# Ajith Kumar Siriwardena\n\nBritish\n| other_names =\n| known_for   =\n| education   = University of Manchester\n| employer    = Manchester Royal Infirmary\n| occupation  = Professor of Hepato-pancreato-biliary Surgery\n| title       =\n| networth    =\n| height      =\n| term        =\n| predecessor =\n| successor   =\n| party       =\n| boards      =\n| spouse      =\n| partner     =\n| children    =\n| parents     =\n| relatives   =\n| signature   =\n| website     =\n| footnotes   =\n}}\nProfessor Ajith Kumar Siriwardena MBChB, M.D., FRCS, is the current professor of hepato-pancreatico-biliary surgery at the University of Manchester, and a consultant hepatobiliary surgeon at the Manchester Royal Infirmary.\nBiography\nHe qualified in medicine from the University of Manchester and trained in surgery in Manchester and Edinburgh. He undertook advanced liver surgical training in Paris and worked as a consultant in the national liver surgery unit in Scotland. He currently provides expertise in liver surgery and pancreas surgery, especially for patients who have had bowel cancer and have then developed metastases in the liver.\nResearch\nProfessor Siriwardena's main research interests are liver metastases from bowel cancer.\nHis work has been published in over 100 peer reviewed articles.\nHe sits on the council of the Society of Academic Research (SARS) as well as on the committee of the Europe and Africa Hepato-pancreato-Biliary Association (EAHPBA).\nReferences"
    }
  ]
}